Canature Health Technology Co., Ltd. (SHE:300272)
China
· Delayed Price · Currency is CNY 7.73
-0.11 (-1.40%)
Apr 29, 2026, 3:04 PM CST
SHE:300272 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 80.07 | 83.58 | 132.45 | 92.56 | 104.86 | Upgrade
|
| Depreciation & Amortization | 92.97 | 72.67 | 76.91 | 75.76 | 52.12 | Upgrade
|
| Other Amortization | 6 | 7.06 | 2.31 | 4.57 | 11.6 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.14 | 0.11 | -2.42 | -1.55 | 0.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 16.11 | 0.05 | 0.09 | 15.47 | 6.52 | Upgrade
|
| Loss (Gain) From Sale of Investments | 41.83 | 30.46 | -5.13 | -3.74 | -35.38 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1.3 | 2.36 | 0.55 | 2.78 | Upgrade
|
| Other Operating Activities | 59.62 | 54.05 | 45.58 | 18.2 | 30.84 | Upgrade
|
| Change in Accounts Receivable | -3.74 | -9.47 | -4.74 | 26.17 | -137.99 | Upgrade
|
| Change in Inventory | -45.69 | -12.33 | 62.38 | -37.84 | -65 | Upgrade
|
| Change in Accounts Payable | 53.93 | 50.79 | 62.6 | -39.9 | 218.53 | Upgrade
|
| Change in Other Net Operating Assets | - | 18.63 | 1.64 | 0.3 | 0.47 | Upgrade
|
| Operating Cash Flow | 299.61 | 289.64 | 374.83 | 155.44 | 186.77 | Upgrade
|
| Operating Cash Flow Growth | 3.44% | -22.73% | 141.15% | -16.78% | 33.00% | Upgrade
|
| Capital Expenditures | -144.72 | -99.66 | -80.24 | -94.58 | -71.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 16.95 | 0.14 | 0.57 | 2.64 | 4.7 | Upgrade
|
| Cash Acquisitions | - | - | - | 0 | 7.06 | Upgrade
|
| Divestitures | - | - | -8.43 | - | 99.88 | Upgrade
|
| Investment in Securities | 117.35 | -181.76 | -262.11 | 27.12 | -41.03 | Upgrade
|
| Other Investing Activities | 5.92 | 0.14 | - | 5.01 | 0.16 | Upgrade
|
| Investing Cash Flow | -4.5 | -280.88 | -349.67 | -59.81 | -0.51 | Upgrade
|
| Long-Term Debt Issued | 1,311 | 1,091 | 1,124 | 518.85 | 409.78 | Upgrade
|
| Total Debt Issued | 1,311 | 1,091 | 1,124 | 518.85 | 409.78 | Upgrade
|
| Long-Term Debt Repaid | -925.6 | -1,168 | -643.52 | -357.88 | -427.33 | Upgrade
|
| Total Debt Repaid | -925.6 | -1,168 | -643.52 | -357.88 | -427.33 | Upgrade
|
| Net Debt Issued (Repaid) | 385.89 | -77.05 | 480.69 | 160.97 | -17.55 | Upgrade
|
| Issuance of Common Stock | - | - | 44.69 | - | 2.29 | Upgrade
|
| Repurchase of Common Stock | - | -29.06 | - | -31.37 | -38 | Upgrade
|
| Common Dividends Paid | -132.57 | -181.47 | -78.16 | -69.87 | -40.86 | Upgrade
|
| Other Financing Activities | -76.41 | -11.67 | -16.94 | -28.75 | -2.49 | Upgrade
|
| Financing Cash Flow | 176.91 | -299.24 | 430.29 | 30.98 | -96.6 | Upgrade
|
| Foreign Exchange Rate Adjustments | -14.84 | 12.34 | 20.45 | 14.82 | 0.84 | Upgrade
|
| Net Cash Flow | 457.18 | -278.14 | 475.9 | 141.43 | 90.49 | Upgrade
|
| Free Cash Flow | 154.89 | 189.98 | 294.59 | 60.85 | 115.48 | Upgrade
|
| Free Cash Flow Growth | -18.47% | -35.51% | 384.12% | -47.30% | 18.70% | Upgrade
|
| Free Cash Flow Margin | 8.41% | 11.25% | 17.62% | 3.66% | 7.64% | Upgrade
|
| Free Cash Flow Per Share | 0.27 | 0.33 | 0.51 | 0.11 | 0.20 | Upgrade
|
| Cash Income Tax Paid | 60.47 | 61.31 | 45.22 | 18.42 | 19.91 | Upgrade
|
| Levered Free Cash Flow | 239.06 | 85.83 | 165.73 | 107.38 | 107.21 | Upgrade
|
| Unlevered Free Cash Flow | 239.06 | 107.38 | 183.5 | 117.91 | 117.39 | Upgrade
|
| Change in Working Capital | 2.87 | 40.36 | 122.68 | -46.38 | 13.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.